ArticleJournal of translational medicine2012

Adoptive cell therapy with autologous tumor infiltrating lymphocytes and low-dose Interleukin-2 in metastatic melanoma patients.

Eva Ellebaek et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.